The Current Ratio as of December 2025 (TTM) for I-Mab (IMAB) is 22.82

According to I-Mab’s latest financial reports and current stock price. The company's current Current Ratio is 22.82. This represents a change of 11.23% compared to the average of 20.51 of the last 4 quarters.

I-Mab (IMAB) Historical Current Ratio (quarterly & annually)

How has IMAB Current Ratio performed in the past?

The mean historical Current Ratio of I-Mab over the last ten years is 7.59. The current 22.82 Current Ratio has changed 29.95% with respect to the historical average. Over the past ten years (40 quarters), IMAB's Current Ratio was at its highest in in the June 2025 quarter at 22.82. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

I-Mab (IMAB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of I-Mab Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

I-Mab (IMAB) Average Current Ratio

How has IMAB Current Ratio performed in the past?

The current Current Ratio of I-Mab (IMAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

I-Mab (IMAB) Current Ratio vs. Peers

How is IMAB’s Current Ratio compared to its peers?

I-Mab’s Current Ratio is greater than Galectin Therapeutics Inc. (0.09), less than Design Therapeutics, Inc. (25.13), greater than DiaMedica Therapeutics Inc. (7.55), greater than Aura Biosciences, Inc. (12.39), greater than Rocket Pharmaceuticals, Inc. (7.30), greater than Annexon, Inc. (5.67), greater than Alpha Tau Medical Ltd. (8.43), greater than LB Pharmaceuticals Inc Common Stock (3.56), greater than enGene Holdings Inc. (10.34), greater than Altimmune, Inc. (17.18),

Build a custom stock screener for I-Mab (IMAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like I-Mab using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

I-Mab (IMAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like I-Mab or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.